Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Update Il y a 4 ans
Reference: NCT00271323

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

- Primary : To determine the safety profile of each treatment group. - Secondary : To determine efficacy in term of overall response, disease free survival and survival at 1 and 2 years.


Inclusion criteria

  • Non-Small Cell Lung Carcinoma

Links